Aviva PLC Agios Pharmaceuticals, Inc. Transaction History

Aviva PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $1.52 Million - $1.98 Million	-34,412 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$33.21 - $46.54 $926,426 - $1.3 Million	-27,896 Reduced 44.77%	34,412 $1.49 Million
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $651,387 - $1.08 Million	19,232 Added 44.65%	62,308 $2.18 Million
Q2 2020 Aug 13, 2020	BUY	$34.45 - $53.48 $1.48 Million - $2.3 Million	43,076 New	43,076 $2.3 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.